Tortoise Investment Management’s Amedisys AMED Stock Holding History

Tortoise Investment Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23	Closed	-$2K	–	745
2022 Q2	$2K	Hold	23	–	–	﹤0.01%	671
2022 Q1	$4K	Hold	23	–	–	﹤0.01%	580
2021 Q4	$4K	Hold	23	–	–	﹤0.01%	553
2021 Q3	$3K	Hold	23	–	–	﹤0.01%	556
2021 Q2	$6K	Hold	23	–	–	﹤0.01%	502
2021 Q1	$6K	Hold	23	–	–	﹤0.01%	479
2020 Q4	$7K	Hold	23	–	–	﹤0.01%	446
2020 Q3	$5K	Hold	23	–	–	﹤0.01%	434
2020 Q2	$5K	Hold	23	–	–	﹤0.01%	412
2020 Q1	$4K	Hold	23	–	–	﹤0.01%	442
2019 Q4	$4K	Hold	23	–	–	﹤0.01%	490
2019 Q3	$3K	Hold	23	–	–	﹤0.01%	498
2019 Q2	$3K	Hold	23	–	–	﹤0.01%	530
2019 Q1	$3K	Buy	+23	New	+$2.89K	﹤0.01%	519

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Tortoise Investment Management's AMED Position: Q3 2022 in Review

Tortoise Investment Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 23 shares — an estimated $2K sold.

Tortoise Investment Management first reported a position in AMED in Q1 2019 and held it in 14 quarters. The position peaked at $7K in Q4 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

Tortoise Investment Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
Tortoise Investment Management sold 23 Amedisys shares in Q3 2022, an estimated $2K.
Tortoise Investment Management first reported a position in Amedisys in Q1 2019 and held it in 14 quarters.
Tortoise Investment Management's Amedisys position peaked at $7K in Q4 2020.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Tortoise Investment Management's 13F filing for Q3 2022, filed 4 Nov 2022.